GLOBE LIFE INC.

GL

CIK 0000320335 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$1.52B
↑+3.6% +$53Mvs FY2024 (Q4)
Operating Income
$645M
↑+6.5% +$39Mvs FY2024 (Q4)
Net Income
$266M
↑+4.3% +$11Mvs FY2024 (Q4)
Gross Profit
$759M
↑+4.3% +$31Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
29/100
  • Profitability
    62ROIC 17.3% (10% = solid, 20%+ = moat)
  • Liquidity
    0Insufficient data
  • Leverage
    81D/E 0.39 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.20x (1.0+ = capital-efficient)
  • Growth
    29Revenue YoY +3.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project GL's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -3.5%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$212.11
Total enterprise IV
$17.50B
Diluted shares
0.08B
Terminal PV
$12.34B (70% of total)
Year-5 FCF
$1.45B
YearProjected FCFDiscounted PV
+1$1.29B$1.17B
+2$1.33B$1.10B
+3$1.37B$1.03B
+4$1.41B$964M
+5$1.45B$903M
Terminal$19.87B$12.34B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$142M
investment in PP&E
Dividends paid (TTM)
$86M
cash returned to holders
Stock buybacks (TTM)
$881M
share count reduction

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$30.81B
everything owned
Total liabilities
$24.84B
everything owed
Stockholders' equity
$5.97B
shareholder claim
Net debt
$2.28B
LT debt minus cash

Recent performance · 70 quarters

Revenue↑+3.6% +$53M
$1.52B
Net Income↑+4.3% +$11M
$266M
Free Cash Flow↑+2.5% +$8M
$330M
Operating Margin↑+3.0pts
26.3%

Drill down